Incyte Corp
INCY
Equity
ISIN null / Valor 134791
NASDAQ (2026-01-20)
USD 102.62-3.38%
Incyte Corp
UMushroom community rating:
About company
Incyte Corp is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for cancer and other diseases.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
41.6%1Y
23.3%3Y
6.49%5Y
Performance
34.6%1Y
30.0%3Y
29.4%5Y
Volatility
20147 M
Market cap (USD)
2,205,966
Daily traded volume (Shares)
68.77 / 67.76
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
